v3.21.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash $ 37,341 $ 17,256
Accounts receivable 200
Inventory 50
Prepaid expenses, deposits, and other current assets 4,141 1,685
Total current assets 41,732 18,941
Fixed assets, net 451 82
Intangible assets, net 47
Other assets 755 755
Total assets 42,985 19,778
Current liabilities:    
Accounts payable 6,080 2,966
Accrued expenses and other current liabilities 1,671 2,325
CARES Act Paycheck Protection Program note payable 300
Senior Secured Convertible Notes - at fair value 10,060
Senior Convertible Note - at fair value 4,600
Total liabilities 7,751 20,251
Commitments and contingencies (Note 6)
Stockholders’ Equity (Deficit):    
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,091,448 at September 30, 2021 and 1,228,075 shares at December 31, 2020 2,352 2,537
Common stock, $0.001 par value. Authorized, 150,000,000 shares; 84,400,822 and 63,819,935 shares outstanding as of September 30, 2021 and December 31, 2020, respectively 84 64
Additional paid-in capital 154,059 87,570
Accumulated deficit (121,625) (88,275)
Total PAVmed Inc. Stockholders’ Equity 34,870 1,896
Noncontrolling interests 364 (2,369)
Total Stockholders’ Equity (Deficit) 35,234 (473)
Total Liabilities and Stockholders’ Equity $ 42,985 $ 19,778

Source